Intervention Review

Inhaled antibiotics for long-term therapy in cystic fibrosis

  1. Gerard Ryan1,*,
  2. Meenu Singh2,
  3. Kerry Dwan3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 31 JAN 2011

DOI: 10.1002/14651858.CD001021.pub2

How to Cite

Ryan G, Singh M, Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD001021. DOI: 10.1002/14651858.CD001021.pub2.

Author Information

  1. 1

    Sir Charles Gairdner Hospital, Department of Respiratory Medicine, Nedlands, Western Australia 6009, Australia

  2. 2

    Post Graduate Institute of Medical Education and Research, Department of Pediatrics, Chandigarh, India

  3. 3

    University of Liverpool, Institute of Child Health, Liverpool, England, UK

*Gerard Ryan, Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Ground Floor B Block, Verdun Street, Nedlands, Western Australia 6009, Australia.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 16 MAR 2011


  1. Current Version

    Inhaled antibiotics for long-term therapy in cystic fibrosis

    Gerard Ryan, Meenu Singh and Kerry Dwan

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD001021.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Nebulised anti-pseudomonal antibiotics for cystic fibrosis

    Gerard Ryan, Somnath Mukhopadhyay and Meenu Singh

    Article first published online: 21 JUL 2003 | DOI: 10.1002/14651858.CD001021